Literature DB >> 28932273

The global impact of IBS: time to think about IBS-specific models of care?

Maura Corsetti1, Peter Whorwell2.   

Abstract

Irritable bowel syndrome (IBS) is a prevalent functional gastrointestinal (GI) disorder that can significantly erode the quality of life (QoL) of sufferers and places a major cost burden on healthcare services. This paper reviews the literature on the impact of IBS on healthcare services and society, including a recent report on the subject, in order to formulate a plan for the future. A completely different model of care for these patients is recommended based on this review and the experience of the two authors who have been treating patients with functional GI disorders for 20 and 35 years, respectively.

Entities:  

Keywords:  IBS; burden; model of care

Year:  2017        PMID： 28932273      PMCID： PMC5598808          DOI： 10.1177/1756283X17718677

Source DB:  PubMed          Journal:  Therap Adv Gastroenterol        ISSN： 1756-283X            Impact factor:   4.409


  45 in total

1.  Avoiding analgesic escalation and excessive healthcare utilization in severe irritable bowel syndrome: a role for intramuscular anticholinergics?

Authors:  James S Pearson; Christine Pollard; Peter J Whorwell
Journal:  Therap Adv Gastroenterol       Date:  2014-11       Impact factor: 4.409

2.  Episodic nature of symptoms in irritable bowel syndrome.

Authors:  Olafur S Palsson; Jeffrey Baggish; William E Whitehead
Journal:  Am J Gastroenterol       Date:  2014-07-01       Impact factor: 10.864

3.  Patients with irritable bowel syndrome-diarrhea have lower disease-specific quality of life than irritable bowel syndrome-constipation.

Authors:  Prashant Singh; Kyle Staller; Kenneth Barshop; Elaine Dai; Jennifer Newman; Sonia Yoon; Shahar Castel; Braden Kuo
Journal:  World J Gastroenterol       Date:  2015-07-14       Impact factor: 5.742

4.  Impact of irritable bowel syndrome on personal relationships and working practices.

Authors:  D B Silk
Journal:  Eur J Gastroenterol Hepatol       Date:  2001-11       Impact factor: 2.566

5.  Health-related quality of life and health care costs in severe, refractory irritable bowel syndrome.

Authors:  F Creed; J Ratcliffe; L Fernandez; B Tomenson; S Palmer; C Rigby; E Guthrie; N Read; D Thompson
Journal:  Ann Intern Med       Date:  2001-05-01       Impact factor: 25.391

Review 6.  Irritable bowel syndrome in developing countries--a disorder of civilization or colonization?

Authors:  K-A Gwee
Journal:  Neurogastroenterol Motil       Date:  2005-06       Impact factor: 3.598

7.  The validity and accuracy of the Work Productivity and Activity Impairment questionnaire--irritable bowel syndrome version (WPAI:IBS).

Authors:  M C Reilly; A Bracco; J-F Ricci; J Santoro; T Stevens
Journal:  Aliment Pharmacol Ther       Date:  2004-08-15       Impact factor: 8.171

8.  International survey of patients with IBS: symptom features and their severity, health status, treatments, and risk taking to achieve clinical benefit.

Authors:  Douglas A Drossman; Carolyn Blank Morris; Susan Schneck; Yuming J B Hu; Nancy J Norton; William F Norton; Stephan R Weinland; Christine Dalton; Jane Leserman; Shrikant I Bangdiwala
Journal:  J Clin Gastroenterol       Date:  2009-07       Impact factor: 3.062

9.  Functional bowel disorders in primary care: factors associated with health-related quality of life and doctor consultation.

Authors:  Victoria Lee; Else Guthrie; Andrew Robinson; Anne Kennedy; Barbara Tomenson; Anne Rogers; David Thompson
Journal:  J Psychosom Res       Date:  2008-02       Impact factor: 3.006
View more
  10 in total

Review 1.  A review of the current concerns about misconduct in medical sciences publications and the consequences.

Authors:  Taraneh Mousavi; Mohammad Abdollahi
Journal:  Daru       Date:  2020-02-19       Impact factor: 3.117

Review 2.  Efficacy and safety of biophenol-rich nutraceuticals in adults with inflammatory gastrointestinal diseases or irritable bowel syndrome: A systematic literature review and meta-analysis.

Authors:  Joanna Giang; Xiao Lan; Megan Crichton; Wolfgang Marx; Skye Marshall
Journal:  Nutr Diet       Date:  2021-05-07       Impact factor: 2.859

3.  Psychosocial Factors Associated With Irritable Bowel Syndrome Development in Chinese College Freshmen.

Authors:  Chen Jiang; Yan Xu; Stuti Sharma; Lei Zhang; Huan Wang; Jun Song; Wei Qian; Tao Bai; Xiaohua Hou
Journal:  J Neurogastroenterol Motil       Date:  2019-04-30       Impact factor: 4.924

4.  A 5Ad Dietary Protocol for Functional Bowel Disorders.

Authors:  Fandi Ibrahim; Philippa Stribling
Journal:  Nutrients       Date:  2019-08-17       Impact factor: 5.717

5.  Reduction in IBS symptom severity is not paralleled by improvement in quality of life in patients with irritable bowel syndrome.

Authors:  Zsa Zsa R M Weerts; Lisa Vork; Zlatan Mujagic; Daniel Keszthelyi; Martine A M Hesselink; Joanna Kruimel; Carsten Leue; Jean W M Muris; Daisy M A E Jonkers; Ad A M Masclee
Journal:  Neurogastroenterol Motil       Date:  2019-05-22       Impact factor: 3.598

6.  The level and prevalence of depression and anxiety among patients with different subtypes of irritable bowel syndrome: a network meta-analysis.

Authors:  Zhichao Hu; Meixuan Li; Liang Yao; Yinshu Wang; Enkang Wang; Jianye Yuan; Fengyun Wang; Kehu Yang; Zhaoxiang Bian; Linda L D Zhong
Journal:  BMC Gastroenterol       Date:  2021-01-07       Impact factor: 3.067

7.  Long-Term Effects of a Web-Based Low-FODMAP Diet Versus Probiotic Treatment for Irritable Bowel Syndrome, Including Shotgun Analyses of Microbiota: Randomized, Double-Crossover Clinical Trial.

Authors:  Dorit Vedel Ankersen; Petra Weimers; Mette Bennedsen; Anne Birgitte Haaber; Eva Lund Fjordside; Moritz Emanuel Beber; Christian Lieven; Sanaz Saboori; Nicolai Vad; Terje Rannem; Dorte Marker; Kristine Paridaens; Suzanne Frahm; Lisbeth Jensen; Malte Rosager Hansen; Johan Burisch; Pia Munkholm
Journal:  J Med Internet Res       Date:  2021-12-14       Impact factor: 5.428

8.  A trial-based economic evaluation of peppermint oil for the treatment of irritable bowel syndrome.

Authors:  Zsa Zsa R M Weerts; Brigitte A B Essers; Daisy M A E Jonkers; Jeresa I A Willems; Deborah J P A Janssen; Ben J M Witteman; Cees H M Clemens; Audrey Westendorp; Ad A M Masclee; Daniel Keszthelyi
Journal:  United European Gastroenterol J       Date:  2021-09-01       Impact factor: 4.623

9.  Hypnotherapy for irritable bowel syndrome: patient expectations and perceptions.

Authors:  Anne-Sophie Donnet; Syed Shariq Hasan; Peter J Whorwell
Journal:  Therap Adv Gastroenterol       Date:  2022-02-15       Impact factor: 4.409

10.  Associations between chronotype, social jetlag, and weekday sleep in women with irritable bowel syndrome.

Authors:  Pei-Lin Yang; Robert L Burr; Horacio O de la Iglesia; Diana T Buchanan; Teresa M Ward; Carol A Landis; Margaret M Heitkemper
Journal:  Chronobiol Int       Date:  2021-02-22       Impact factor: 2.877
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.